Clinical trial
Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone…
NCT00364442 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00364442 |
|---|---|
| Title | Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics |
| Official title | A Repeat Dose, Randomised, Double Blind, 2-way Crossover Study to Assess the Safety and Systemic Exposure of an Investigational Formulation Compared to Concurrent Administration of Individual Fluticasone Propionate 50 and Salmeterol 50 DISKUS Inhalers in Subjects Aged 18 - 55 Years With Mild Asthma |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | fluticasone propionate/salmeterol |
| Enrollment | 12 |
| Start date | Jan 28, 2005 |
| Primary completion | Apr 13, 2005 |
| Completion | Apr 13, 2005 |
| First posted | Aug 15, 2006 |
| Last update posted | Sep 29, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: